cilostazol

Generic: cilostazol

Labeler: avkare
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name cilostazol
Generic Name cilostazol
Labeler avkare
Dosage Form TABLET
Routes
ORAL
Active Ingredients

cilostazol 100 mg/1

Manufacturer
AvKARE

Identifiers & Regulatory

Product NDC 42291-453
Product ID 42291-453_485d4436-cc9f-8ea9-e063-6294a90a53be
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077030
Listing Expiration 2027-12-31
Marketing Start 2022-04-12

Pharmacologic Class

Established (EPC)
phosphodiesterase 3 inhibitor [epc]
Mechanism of Action
phosphodiesterase 3 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 42291453
Hyphenated Format 42291-453

Supplemental Identifiers

RxCUI
242461
UNII
N7Z035406B
NUI
N0000175598 N0000175086

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cilostazol (source: ndc)
Generic Name cilostazol (source: ndc)
Application Number ANDA077030 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (42291-453-60)
source: ndc

Packages (1)

42291-453-60 60 TABLET in 1 BOTTLE (42291-453-60)

Ingredients (1)

cilostazol (100 mg/1)

Linked Drug Pages (1)

cilostazol ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "485d4436-cc9f-8ea9-e063-6294a90a53be", "openfda": {"nui": ["N0000175598", "N0000175086"], "unii": ["N7Z035406B"], "rxcui": ["242461"], "spl_set_id": ["dc7c2c25-36a1-e3fd-e053-2995a90adabc"], "pharm_class_epc": ["Phosphodiesterase 3 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 3 Inhibitors [MoA]"], "manufacturer_name": ["AvKARE"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (42291-453-60)", "package_ndc": "42291-453-60", "marketing_start_date": "20220412"}], "brand_name": "cilostazol", "product_id": "42291-453_485d4436-cc9f-8ea9-e063-6294a90a53be", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 3 Inhibitor [EPC]", "Phosphodiesterase 3 Inhibitors [MoA]"], "product_ndc": "42291-453", "generic_name": "cilostazol", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "cilostazol", "active_ingredients": [{"name": "CILOSTAZOL", "strength": "100 mg/1"}], "application_number": "ANDA077030", "marketing_category": "ANDA", "marketing_start_date": "20220412", "listing_expiration_date": "20271231"}